Suppression of apolipoprotein C-II amyloid formation by the extracellular chaperone, clusterin

European Journal of Biochemistry

Volumn 269, Issue 11, 2002, Pages 2789-2794

  Hatters, Danny M ^a   Wilson, Mark R ^b   Easterbrook Smith, Simon B ^c   Howlett, Geoffrey J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WOLLONGONG   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Amyloid formation; Analytical ultracentrifugation; Nucleation; Protein folding; Substoichiometric inhibition

Indexed keywords

AMYLOID; APOLIPOPROTEIN C2; CHAPERONE; CLUSTERIN; LIPID; MONOMER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISSOCIATION; DOSE TIME EFFECT RELATION; EXTRACELLULAR SPACE; GROWTH INHIBITION; HUMAN; INCUBATION TIME; MORPHOLOGY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEDIMENTATION; SPERM; STOICHIOMETRY;

AMYLOID; APOLIPOPROTEIN C-II; APOLIPOPROTEINS C; CLUSTERIN; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; THIAZOLES;

EID: 0036274782     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.02957.x     Document Type: Article

References (35)

1. Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources
2. Isolation and properties of human apolipoproteins C-I, C-II, and C-III
3. Behavior of apolipoprotein C-II in an aqueous solution
4. Submicellar phospholipid accelerates amyloid formation by apolipoprotein C-II
5. NMR structure of human apolipoprotein C-II in the presence of sodium dodecyl sulfate
6. Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops
7. The structural basis for amyloid formation by apolipoproteins
8. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques
9. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis
10. Polymorphism of apolipoprotein A-II (apoA-II) among inbred strains of mice. Relationship between the molecular type of apoA-II and mouse senile amyloidosis
11. A new human hereditary amyloidosis: The result of a stop-codon mutation in the apolipoprotein AII gene
12. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis
13. Is Alzheimer's disease an apolipoprotein E amyloidosis?
14. Review: Formation and properties of amyloid-like fibrils derived from alpha-synuclein and related proteins
15. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo
16. Small heat shock proteins inhibit in vitro Aβ (1-42) amyloidogenesis
17. The molecular chaperone αB-crystallin enhances amyloid β neurotoxicity
18. The molecular chaperone, α-crystallin, inhibits amyloid formation by apolipoprotein C-II
19. Clusterin has chaperone-like activity similar to that of small heat shock proteins
20. Clusterin is a secreted mammalian chaperone
21. Human seminal clusterin (SP-40,40). Isolation and characterization
22. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis
23. Sulfated glycoprotein 2: New relationships of this multifunctional protein to neurodegeneration
24. Apolipoprotein J (clusterin) and Alzheimer's disease
25. Apolipoprotein J and Alzheimer's amyloid β solubility
26. Clusterin prevents aggregation of neuropeptide 106-126 in vitro
27. Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress
28. Isolation and characterization of recombinant human apolipoprotein C-II expressed in Escherichia coli
29. Clusterin binds by a multivalent mechanism to the Fc and Fab regions of IgG
30. Determination of the sedimentation coefficient distribution by least-squares boundary modeling
31. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling
32. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma
33. pH-dependent changes in the in vitro ligand-binding properties and structure of human clusterin
34. Analysis of protein aggregation kinetics
35. Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain